Industry
Arquer and Euro Diagnostica Partner on Noninvasive Test for Bladder Cancer
Arquer Diagnostics, a company which has developed a high-sensitivity, high-specificity, ELISA-based urine test for cancer, has signed an agreement with Euro Diagnostica for the manufacturing and supply of Arquer’s Mcm5-ELISA test for the diagnosis of bladder cancer. More...14 Feb 2016
IVD Sector in India Shows Stable Growth and Exhibits Potential
According to a new report, the in vitro diagnostic testing sector in India is estimated to have reached USB 782 million in 2015 and modernizing healthcare infrastructure and steady migration from manual to automated processes will support additional growth. More...31 Jan 2016
Thermo Fisher to Acquire Affymetrix, Strengthens Biosciences Leadership
Thermo Fisher Scientific and Affymetrix have announced that their boards of directors have unanimously approved Thermo Fisher’s acquisition of Affymetrix for USD 14.00 per share in cash, representing purchase price of approximately USD 1.3 billion More...12 Jan 2016
Top Five IVD Sector Trends of 2015 Announced
Among the in vitro diagnostic testing trends in 2015 were smaller molecular instruments, better information technology systems, and progress on use of sequencing in clinical medicine. These and additional findings were based on research covered in three new healthcare market reports. More...21 Dec 2015
Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
New
Staining System
RAL DIFF-QUIK
New
Anti-Thyroid Peroxidase Assay
LIAISON Anti-TPO
In Other News
Challenge to Reduce Sexually Transmitted Disease Infections Spurs Growth in IVD Sector
Growth Continues in Infectious Disease Diagnostics
Gene Expression Informatics Companies Collaborate on Diagnostics of Age-Related Diseases
Molecular Diagnostics Sector Reaches New Peak
Distribution Agreement Reached for Multiplexed Assay Platforms
Enhanced IT Propels Clinical Laboratory Services Sector
Erba Mannheim Acquires Maxmat for Diagnostics Analyzers and Advanced Development
Diagnostic Company Acquisition to Ease Market Entry and Shorten Development Time for New Tests
Supply Agreement to Boost Molecular Diagnostic Testing in Scandinavia
Clinical Applications Transforming Flow Cytometry Sector
Partners to Develop and Commercialize Noninvasive Tests for Bladder Cancer
Distribution Agreement to Improve Automated Hemostasis Diagnostics
Innovative Microbial Diagnostics Developer Acquired by Biomedical Giant
Alere Strengthens Core Strategy Through Two New Transactions
Cancer Genetics Expands Access to Proprietary Diagnostics Through Agreement with Harvard Pilgrim
QIAGEN Expands Diagnostics Menu in Partnership with Seegene
Next Generation Sequencing Provides Responsiveness for Identifying Resistant Pathogens
Hitachi High-Tech and QIAGEN Partner to Advance Diagnostics
Cloud-Based Systems Becoming Key Pillar in eHealth Strategy
Advanced NGS Partnership Paves Way for More Accessible Personalized Medicine in Cancer
New Point of Care Test for Anemia Developed
Main Factors Driving Revenue Growth in Clinical Chemistry Identified
Bio-Rad Grants Beckman Coulter Exclusive Distribution for Two Infectious Disease Tests
LabMedica Industry News channel reports on mergers and takeovers, on cooperative agreements and on trends in the IVD industry worldwide.
